List of Treatments for Myeloma

See what members are saying about myeloma treatments, the side effects to expect, and the drug basics.

All treatment information is medically reviewed · July 13, 2026

Ninlaro (Ixazomib) for Multiple Myeloma

Ninlaro (ixazomib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Osenvelt (Denosumab-Bmwo) for Multiple Myeloma

Osenvelt (denosumab-bmwo) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for preventing skeletal-related events in adults with multiple myeloma.

Oziltus (Denosumab-Mobz) for Multiple Myeloma

Oziltus (denosumab-mobz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent bone problems, also called skeletal-related events, in people with multiple myeloma.

Pomalyst (Pomalidomide) for Multiple Myeloma

Pomalyst (pomalidomide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Revlimid (Lenalidomide) for Multiple Myeloma

Revlimid (lenalidomide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Sarclisa (Isatuximab-Irfc) for Multiple Myeloma

Sarclisa (isatuximab-irfc) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple myeloma. It is used with other medicines in certain approved treatment settings.

Talvey (Talquetamab-Tgvs) for Myeloma

Talvey (talquetamab-tgvs) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma.

Tecvayli (Teclistamab-Cqyv) for Multiple Myeloma

Tecvayli (teclistamab-cqyv) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Thalomid (Thalidomide) for Multiple Myeloma

Thalomid (thalidomide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with newly diagnosed multiple myeloma.

Velcade (Bortezomib) for Multiple Myeloma

Velcade (bortezomib) is a prescription medication Approved by the U.S. Food and Drug Administration (FDA) for treating adults with multiple myeloma.

Wyost (Denosumab-Bbdz) for Multiple Myeloma

Wyost (denosumab-bbdz) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events in adults with multiple myeloma.

Xbryk (Denosumab-Dssb)

Xbryk (denosumab-dssb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help prevent skeletal-related events in adults with multiple myeloma.

Xgeva (Denosumab) for Multiple Myeloma

Xgeva (denosumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for preventing skeletal-related events in adults with multiple myeloma.

Xpovio (Selinexor) for Multiple Myeloma

Xpovio (selinexor) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with multiple myeloma. It is used with other medicines in certain approved treatment settings.

Xtrenbo (Denosumab-Qbde) for Multiple Myeloma

Xtrenbo (denosumab-qbde) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to prevent bone problems, also called skeletal-related events, in people with multiple myeloma.